Question · asked by 1 review
PERPHENAZINE vs antipsychotics: Other adverse events: any serious adverse event ‐ short and long term
- Population
- patients with schizophrenia
- Intervention
- PERPHENAZINE
- Comparison
- antipsychotics
- Outcome
- Other adverse events: any serious adverse event ‐ short and long term
It is very uncertain whether PERPHENAZINE changes other adverse events: any serious adverse event ‐ short and long term compared with ANY ANTIPSYCHOTICS (very low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
PERPHENAZINE vs ANY ANTIPSYCHOTICS Other adverse events: any serious adverse event ‐ short and long term · patients with schizophrenia It is very uncertain whether PERPHENAZINE changes other adverse events: any serious adverse event ‐ short and long term compared with ANY ANTIPSYCHOTICS (very low certainty). Perphenazine for schizophrenia (2015) · Cochrane Headline outcomes only | RR 0.98 [0.68, 1.41] | 2 studies · 1760 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Perphenazine for schizophrenia 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.